Sign in Sign Up Free

Foresite Capital Fund IV, L.P. (“FCF IV”)

Activist investor & 5%+ owner · SC 13D/13G filings

Total Filings

17

Stocks Covered

7

Latest Filing

Oct 31, 2024

Filings

Lyell Immunopharma, Inc.

SC 13G · Oct 31, 2024

3.2%

8.3M shares

Kinnate Biopharma Inc.

SC 13D/A · Apr 5, 2024

0.0%

0 shares

Kinnate Biopharma Inc.

SC 13D/A · Feb 22, 2024

20.5%

9.7M shares

Aclaris Therapeutics, Inc.

SC 13G/A · Feb 13, 2024

0.0%

0 shares

Pharvaris N.V.

SC 13G/A · Feb 13, 2024

7.8%

4.0M shares

Kinnate Biopharma Inc.

SC 13D/A · Nov 17, 2023

20.5%

9.7M shares

Kinnate Biopharma Inc.

SC 13D/A · Nov 14, 2023

20.5%

9.7M shares

Kinnate Biopharma Inc.

SC 13D/A · May 10, 2023

20.8%

9.7M shares

Kinnate Biopharma Inc.

SC 13D/A · Feb 22, 2023

20.8%

9.7M shares

Aclaris Therapeutics, Inc.

SC 13G/A · Feb 13, 2023

4.2%

2.8M shares

Lyell Immunopharma, Inc.

SC 13G/A · Feb 13, 2023

4.0%

10.0M shares

Pharvaris N.V.

SC 13G/A · Feb 13, 2023

9.6%

3.2M shares

Quantum-Si Incorporated

SC 13D/A · Jun 28, 2022

2.0%

2.3M shares

Keros Therapeutics, Inc.

SC 13G/A · Feb 11, 2022

0.0%

0 shares

Pharvaris N.V.

SC 13G/A · Feb 11, 2022

9.8%

3.3M shares

Nurix Therapeutics, Inc.

SC 13G/A · Feb 11, 2022

2.7%

1.2M shares

Lyell Immunopharma, Inc.

SC 13G · Feb 11, 2022

5.5%

13.3M shares